[HTML][HTML] β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.
C Xu, ZB Jiang, L Shao, ZM Zhao, XX Fan… - Pharmacological …, 2023 - europepmc.org
Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
C Xu, ZB Jiang, L Shao, ZM Zhao… - Pharmacological …, 2023 - pubmed.ncbi.nlm.nih.gov
Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.
C Xu, ZB Jiang, L Shao, ZM Zhao, XX Fan, X Sui, LL Yu… - 2023 - cabidigitallibrary.org
Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …
growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase …